NEW YORK (GenomeWeb) – Rosetta Genomics said today that it has received notification that it is no longer in compliance with the Nasdaq's $1 minimum bid price requirement for continued listing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.